Booth No.6F-22
CategoryIngredients
Whale Corporation
Booth No.：6F-22
Category：Ingredients
Company Information
Email：
qin.yi@whalecorporation.com
TEL： +86-186-1010-6369
Address： 2F., Zhoungdu Technology Building., No.35 West 4th Ring Soth Rd., Feng Tai District., Beijing CHINA
Headquartered in Beijing, China, Whale Corporation is an industry leader providing high-quality, timely CRDMO (Contract Research, Development, Manufacturing, and Outsourcing) services for pharmaceutical intermediates and APIs; Whale Corporation specializes in a wide range of chemical reactions: catalytic hydrogenation, bromination, chlorination, diazotization, oxidation, reduction, metal reagents like Grignard, lithium, and zinc, noble metal coupling, Friedel-Crafts reactions, acyl chloride formation, photochemistry, heterocyclic chemistry, and etc. The company's facilities and well-established reaction conditions enable handling of temperatures from -100°C to 240°C and pressures from 0 to 30 atm, including anhydrous and oxygen-free reactions.
Company information
| Address | 2F., Zhoungdu Technology Building., No.35 West 4th Ring Soth Rd., Feng Tai District., Beijing CHINA |
|---|---|
| TEL | +86-186-1010-6369 |
| qin.yi@whalecorporation.com |
| Product Classification |
Beraprost Sodium; API; cas:88475-69-8 Calcifediol; API; cas:19356-17-3 Calcitriol; API; cas:32222-06-3 Dapagliflozin; API;cas: 461432-26-8 Eliglustat; API; cas:491833-29-5 Limaprost; API; cas:74397-12-9 Sodium Stearyl Fumarate; API; cas:4070-80-8 Apixaban; Intermediates; cas:881386-01-2; 1267610-26-3 Dotinurad; Intermediates; cas:37908-97-7 Orforglipron (LY3502970); Intermediates; cas:7254-19-5; 99725-44-7 Ramelteon; Intermediates; cas:196597-78-1 Salcaprozate Sodium (SNAC); Intermediates; cas:29823-21-0; 2037-95-8 Tegoprazan; Intermediates; cas:2168520-25-8; 942195-86-0 Zavegepant; Intermediates; cas:855778-84-6; 349535-15-5 isopropyl3-oxocyclobutane-1-carboxylate; cas:130111-95-4 3-Oxocyclobutanecarboxylic acid; cas:23761-23-1 Paliperidone; Intermediates; cas:130049-82-0; 84163-13-3; 63234-80-0 Fluralaner; Intermediates; cas:130336-16-2; 1171331-39-7 Bilastine; Intermediates; cas: 38385-95-4; 953071-73-3; 1181267-33-3 |
|---|
Product introduction
Beraprost Sodium; API; cas:88475-69-8Calcifediol; API; cas:19356-17-3Calcitriol; API; cas:32222-06-3Dapagliflozin; API;cas: 461432-26-8 Eliglustat; API; cas:491833-29-5Limaprost; API; cas:74397-12-9Sodium Stearyl Fumarate; API; cas:4070-80-8Apixaban; Intermediates; cas:881386-01-2; 1267610-26-3 Dotinurad; Intermediates; cas:37908-97-7Orforglipron (LY3502970); Intermediates; cas:7254-19-5; 99725-44-7Ramelteon; Intermediates; cas:196597-78-1Salcaprozate Sodium (SNAC); Intermediates; cas:29823-21-0; 2037-95-8Tegoprazan; Intermediates; cas:2168520-25-8; 942195-86-0Zavegepant; Intermediates; cas:855778-84-6; 349535-15-5isopropyl3-oxocyclobutane-1-carboxylate; cas:130111-95-43-Oxocyclobutanecarboxylic acid; cas:23761-23-1Paliperidone; Intermediates; cas:130049-82-0; 84163-13-3; 63234-80-0Fluralaner; Intermediates; cas:130336-16-2; 1171331-39-7Bilastine; Intermediates; cas: 38385-95-4; 953071-73-3; 1181267-33-3